Morocco Launches Rare Disease Hub
Morocco has established a national hub to improve the diagnosis, treatment, and research of rare diseases. The initiative will act as a central resource to advance care and address challenges for patients and families affected by these conditions in the country.
The new Precision Medicine Hub is a joint initiative between the Fondation Mohammed VI des Sciences et de la Santé (FM6SS) and AstraZeneca, located at the Mohammed VI International University Hospital Complex in Rabat. Its launch on International Rare Disease Day marks a significant step towards a planned national Center of Excellence for Rare Diseases. This initiative aims to address significant hurdles for patients, who often face long and difficult paths to diagnosis, as well as limited access to specialized tests and fragmented care. A core objective of the hub is to shorten the time it takes to get a diagnosis and to establish structured, multidisciplinary care pathways for patients. The collaboration will also focus on integrating advanced genomic and molecular profiling into routine clinical practice to improve the precision of diagnoses and treatments. The partnership agreement between the foundation and the pharmaceutical company is built on five key pillars. These include: accelerating diagnosis, training healthcare professionals, improving equitable access to innovative therapies, and strengthening patient care. A crucial fifth pillar is the creation of a national patient registry to better understand the prevalence of various rare diseases within Morocco. Patient advocacy groups, including the Moroccan Alliance for Rare Diseases (AMRM), were key participants in the hub's launch, highlighting the importance of patient engagement in shaping care strategies. The center will serve as a national referral hub, working to standardize care, generate real-world data, and build the capacity of healthcare professionals across the country. The prevalence of rare diseases in Morocco is influenced by a high rate of consanguineous marriages, which increases the incidence of autosomal recessive disorders. This genetic landscape presents unique challenges but also offers opportunities for research into new pathogenic variants and therapeutic targets. While there are over 7,000 known rare diseases globally, many patients in Morocco and the wider region experience diagnostic journeys that can average six to eight years. The new hub aims to directly address this "diagnostic odyssey" by creating a coordinated national framework. The initiative is part of a broader move to modernize Morocco's healthcare system by improving early detection and monitoring of complex conditions. Ultimately, the goal is to provide faster, more expert, and more equitable care for all Moroccan patients affected by rare diseases.
